Loading clinical trials...

Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery | Clinical Trials | Clareo Health

RECRUITINGNANCT06156943

Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery

High-risk patients scheduled for lung resection surgery are increasing and theoretically eligible to perioperative individualized goal-directed fluid therapy (GDFT). However, thoracic surgery is chall...

Lead sponsor: Hospices Civils de Lyon•10 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

FELLAHI Jean-Luc, M.D., Ph.D.,

CONTACT

(+33) 4 72 11 89 33 [email protected]

SAMSON Géraldine

CONTACT

(+33) 4.27.85.53.26 [email protected]

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment722

Start dateDec 2024

Last updatedDec 24, 2024

Condition

High-risk Lung Resection Surgery

Locations shown

Hopital Louis Pradel

Bron

CHU Dijon Bourgogne

Dijon

Hôpital Arnaud de Villeneuve - CHU Montpellier

Montpellier

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions